184 related articles for article (PubMed ID: 35797877)
21. Preparation of
Westrøm S; Generalov R; Bønsdorff TB; Larsen RH
Nucl Med Biol; 2017 Aug; 51():1-9. PubMed ID: 28486098
[TBL] [Abstract][Full Text] [Related]
22. Cyclotron production of Ac-225 for targeted alpha therapy.
Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A
Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913
[TBL] [Abstract][Full Text] [Related]
23. Actinium-225 targeted alpha particle therapy for prostate cancer.
Bidkar AP; Zerefa L; Yadav S; VanBrocklin HF; Flavell RR
Theranostics; 2024; 14(7):2969-2992. PubMed ID: 38773983
[TBL] [Abstract][Full Text] [Related]
24. 225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets.
Weidner JW; Mashnik SG; John KD; Ballard B; Birnbaum ER; Bitteker LJ; Couture A; Fassbender ME; Goff GS; Gritzo R; Hemez FM; Runde W; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2590-5. PubMed ID: 22944532
[TBL] [Abstract][Full Text] [Related]
25. Separation of 103Ru from a proton irradiated thorium matrix: A potential source of Auger therapy radionuclide 103mRh.
Mastren T; Radchenko V; Hopkins PD; Engle JW; Weidner JW; Copping R; Brugh M; Nortier FM; Birnbaum ER; John KD; Fassbender ME
PLoS One; 2017; 12(12):e0190308. PubMed ID: 29272318
[TBL] [Abstract][Full Text] [Related]
26. A High Separation Factor for
Da Silva I; Johnson TR; Mixdorf JC; Aluicio-Sarduy E; Barnhart TE; Nickles RJ; Engle JW; Ellison PA
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946596
[No Abstract] [Full Text] [Related]
27. Pairing of thorium with selected primary target materials in tandem configurations: Co-production of
Steyn GF; Motetshwane MA; Szelecsényi F; Brümmer JW
Appl Radiat Isot; 2021 Feb; 168():109514. PubMed ID: 33334657
[TBL] [Abstract][Full Text] [Related]
28. Targeted alpha therapy with bismuth-213 and actinium-225: Meeting future demand.
Bruchertseifer F; Kellerbauer A; Malmbeck R; Morgenstern A
J Labelled Comp Radiopharm; 2019 Sep; 62(11):794-802. PubMed ID: 31369165
[TBL] [Abstract][Full Text] [Related]
29. Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV.
Weidner JW; Mashnik SG; John KD; Hemez F; Ballard B; Bach H; Birnbaum ER; Bitteker LJ; Couture A; Dry D; Fassbender ME; Gulley MS; Jackman KR; Ullmann JL; Wolfsberg LE; Nortier FM
Appl Radiat Isot; 2012 Nov; 70(11):2602-7. PubMed ID: 22940414
[TBL] [Abstract][Full Text] [Related]
30. Targeted Alpha Therapy: Current Clinical Applications.
Guerra Liberal FDC; O'Sullivan JM; McMahon SJ; Prise KM
Cancer Biother Radiopharm; 2020 Aug; 35(6):404-417. PubMed ID: 32552031
[TBL] [Abstract][Full Text] [Related]
31. An overview of targeted alpha therapy.
Kim YS; Brechbiel MW
Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
[TBL] [Abstract][Full Text] [Related]
32. Targeted alpha therapy: evidence for potential efficacy of alpha-immunoconjugates in the management of micrometastatic cancer.
Allen BJ
Australas Radiol; 1999 Nov; 43(4):480-6. PubMed ID: 10901964
[TBL] [Abstract][Full Text] [Related]
33. The development of
Semenishchev VS; Nedobukh TA; Voronina AV; Kirichenko IV; Malyshev AS; Kirillov EV
Appl Radiat Isot; 2020 Dec; 166():109382. PubMed ID: 32877864
[TBL] [Abstract][Full Text] [Related]
34. Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties.
Ree SM; Greenwood H; Young JD; Roberts R; Livens FR; Heath SL; Sosabowski JK
Nucl Med Commun; 2024 Jun; 45(6):465-473. PubMed ID: 38465420
[TBL] [Abstract][Full Text] [Related]
35. Radiochemical Quality Control Methods for Radium-223 and Thorium-227 Radiotherapies.
Hasson A; Jiang W; Benabdallah N; Lu P; Longtine MS; Beattie BJ; Summer L; Zhang H; Wahl RL; Abou DS; Thorek DLJ
Cancer Biother Radiopharm; 2023 Feb; 38(1):15-25. PubMed ID: 36149725
[No Abstract] [Full Text] [Related]
36. Thorium-229 quantified in historical Thorium-228 capsules.
Boden S; Vints K; Cagno S; Maertens D; Van Hecke K; Cardinaels T
Appl Radiat Isot; 2017 Feb; 120():40-44. PubMed ID: 27907882
[TBL] [Abstract][Full Text] [Related]
37. High Separation Factor, High Molar Activity, and Inexpensive Purification Method for the Production of Pure
Saghez BS; Yang H; Radchenko V
Inorg Chem; 2024 Mar; 63(12):5330-5340. PubMed ID: 38324916
[No Abstract] [Full Text] [Related]
38. Evaluation of the separation and purification of
Ivanov PI; Collins SM; van Es EM; García-Miranda M; Jerome SM; Russell BC
Appl Radiat Isot; 2017 Jun; 124():100-105. PubMed ID: 28363158
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of lanthanum phosphate nanoparticles as carriers for (223)Ra and (225)Ra for targeted alpha therapy.
Rojas JV; Woodward JD; Chen N; Rondinone AJ; Castano CH; Mirzadeh S
Nucl Med Biol; 2015 Jul; 42(7):614-20. PubMed ID: 25900730
[TBL] [Abstract][Full Text] [Related]
40. Harnessing
Yang H; Wilson JJ; Orvig C; Li Y; Wilbur DS; Ramogida CF; Radchenko V; Schaffer P
J Nucl Med; 2022 Jan; 63(1):5-13. PubMed ID: 34503958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
